Evaluation of 3,3′-Diindolylmethane with Gardasil Quadrivalent HPV Vaccine in K14-HPV16-Transgenic Mice Cervical Histology

被引:0
|
作者
Sepkovic, Daniel W. [1 ]
Pagan, Doris V. [1 ]
Stein, Johann [1 ]
Carlisle, Antoine D. [1 ]
Ksieski, H. Barbara [1 ]
Auborn, Karen [2 ]
Nyirenda, Themba [1 ]
Bradlow, H. Leon [1 ]
机构
[1] Hackensack Univ, Med Center, David & Alice Jurist Inst Res, Hackensack, NJ USA
[2] North Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA
来源
IN VIVO | 2013年 / 27卷 / 03期
关键词
3,3 '-Diindolylmethane (DIM); Gardasil Quadrivalent HPV vaccine; cervical intraepithelial neoplasia (CIN); human papilloma virus (HPV); BREAST-CANCER CELLS; HUMAN-PAPILLOMAVIRUS ONCOPROTEINS; TYPE-16 TRANSGENIC MICE; ESTROGEN METABOLISM; MOUSE MODEL; IN-VITRO; INDOLE-3-CARBINOL; CARCINOGENESIS; GENE; PAPILLOMATOSIS;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The effects of 3,3'-diindolylmethane (DIM) together with the Gardasil vaccine on cervical histology were evaluated using the K14-HPV16-transgenic mouse model. The possibility that DIM could enhance the efficacy of this preventive vaccine in this model was explored. Materials and Methods: Transgenic mice were given 1000 mg/kg of DIM in the diet for 28 weeks. The mice were injected with Gardasil Quadrivalent HPV vaccine. Some mice were sacrificed at 28 weeks. Other groups were removed from the DIM diet after 28 weeks to a diet with no DIM for either 4 or 8 weeks. Results: Cervical histology indicated that a high percentage of transgenic mice fed DIM and vaccinated with Gardasil manifested normal cervical epitheliums at 4 weeks after DIM discontinuation. Conclusion: Vaccination pre-supplemented with DIM may provide with a window of protection of at least four weeks in this transgenic model. However, extrapolation to the effect in humans is beyond the limited scope of the histological data presented here.
引用
收藏
页码:299 / 304
页数:6
相关论文
共 42 条
  • [1] Results from a Dose-Response Study Using 3,3′-Diindolylmethane in the K14-HPV16 Transgenic Mouse Model: Cervical Histology
    Sepkovic, Daniel W.
    Stein, Johann
    Carlisle, Antoine D.
    Ksieski, H. Barbara
    Auborn, Karen
    Raucci, Laura
    Nyirenda, Themba
    Bradlow, H. Leon
    [J]. CANCER PREVENTION RESEARCH, 2011, 4 (06) : 890 - 896
  • [2] 3,3′-Diindolylmethane Increases Serum Interferon-γ Levels in the K14-HPV16 Transgenic Mouse Model for Cervical Cancer
    Sepkovic, Daniel W.
    Raucci, Laura
    Stein, Johann
    Carlisle, Antoine D.
    Auborn, Karen
    Ksieski, H. Barbara
    Nyirenda, Themba
    Bradlow, H. Leon
    [J]. IN VIVO, 2012, 26 (02): : 207 - 211
  • [3] Evaluation of Quadrivalent HPV 6/11/16/18 Vaccine Efficacy Against Cervical Disease in Subjects with Prior Vaccine HPV Type Infection
    Ferris, D.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E152 - E152
  • [4] Diindolylmethane Inhibits Cervical Dysplasia, Alters Estrogen Metabolism, and Enhances Immune Response in the K14-HPV16 Transgenic Mouse Model
    Sepkovic, Daniel W.
    Stein, Johann
    Carlisle, Antoine D.
    Ksieski, H. Barbara
    Auborn, Karen
    Bradlow, H. Leon
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (11) : 2957 - 2964
  • [5] Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice
    Arbeit, JM
    Riley, RR
    Huey, B
    Porter, C
    Kelloff, G
    Lubet, R
    Ward, JM
    Pinkel, D
    [J]. CANCER RESEARCH, 1999, 59 (15) : 3610 - 3620
  • [6] Oral epithelial alterations in K14-HPV16 transgenic mice.
    Murrah, VA
    Gilchrist, EP
    Arbeit, JM
    [J]. JOURNAL OF DENTAL RESEARCH, 2000, 79 : 167 - 167
  • [7] Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection
    Olsson, Sven-Eric
    Kjaer, Susanne K.
    Sigurdsson, Kristjan
    Iversen, Ole-Erik
    Hernandez-Avila, Mauricio
    Wheeler, Cosette M.
    Perez, Gonzalo
    Brown, Darron R.
    Koutsky, Laura A.
    Tay, Eng Hseon
    Garcia, Patricia
    Ault, Kevin A.
    Garland, Suzanne M.
    Leodolter, Sepp
    Tang, Grace W. K.
    Ferris, Daron G.
    Paavonen, Jorma
    Lehtinen, Matti
    Steben, Marc
    Bosch, F. Xavier
    Dillner, Joakim
    Joura, Elmar A.
    Majewski, Slawomir
    Munoz, Nubia
    Myers, Evan R.
    Villa, Luisa L.
    Taddeo, Frank J.
    Roberts, Christine
    Tadesse, Amha
    Bryan, Janine
    Maansson, Roger
    Vuocolo, Scott
    Hesley, Teresa M.
    Saah, Alfred
    Barr, Eliav
    Haupt, Richard M.
    [J]. HUMAN VACCINES, 2009, 5 (10): : 696 - 704
  • [8] Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice
    Coussens, LM
    Hanahan, D
    Arbeit, JM
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1996, 149 (06): : 1899 - 1917
  • [9] Indole-3-carbinol and diindolylmethane induce apoptosis of human cervical cancer cells and in murine HPV16-transgenic preneoplastic cervical epithelium
    Chen, DZ
    Qi, M
    Auborn, KJ
    Carter, TH
    [J]. JOURNAL OF NUTRITION, 2001, 131 (12): : 3294 - 3302
  • [10] Cystatin C Deficiency Promotes Epidermal Dysplasia in K14-HPV16 Transgenic Mice
    Yu, Weifang
    Liu, Jian
    Shi, Michael A.
    Wang, Jianan
    Xiang, Meixiang
    Kitamoto, Shiro
    Wang, Bing
    Sukhova, Galina K.
    Murphy, George F.
    Orasanu, Gabriela
    Grubb, Anders
    Shi, Guo-Ping
    [J]. PLOS ONE, 2010, 5 (11):